Specific, Consistent ICD-10 Coding Key to Timely Payments

Share this content:
Specific, Consistent ICD-10 Coding Key to Timely Payments
Specific, Consistent ICD-10 Coding Key to Timely Payments

TUESDAY, Dec. 22, 2015 (HealthDay News) -- In order to prevent denials, it is important to code correctly within the International Classification of Diseases, Tenth Revision (ICD-10), with specificity matching documentation, according to an article published in Medical Economics.

Noting that payers are currently going easy on specificity in coding of ICD-10, but that this largess is not likely to last, the article emphasizes the importance of coding correctly in order to prevent payment delays and possible loss of payment.

A firm providing financial management and support services offered four tips for making sure the right codes are used to prevent denials. They note the importance of not leaving code selection to the electronic health record and checking the selections against the documentation. For those using encounter forms for billing, the forms should accommodate all the components needed for accurate coding, including laterality, upper and lower, initial versus subsequent encounter, etc. Code selection should be made as specific as possible, but coding should not be more specific than documentation. Payers' coding policies should be researched; these may differ from Medicare reimbursement and they may need addition of specific modifiers or want specific codes to be used.

"It is still best to document what you did, do what you documented, and accurately report what [you] have done that is medically necessary to the highest level of specificity," according to feedback from an ICD-10 Diary physician.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths